Jane Foo
Impact in
-
- Cancer, Lipids, and Metabolism
- MicroRNA in disease regulation
-
- Prostate Cancer Treatment and Research
Papers in
-
- Ubiquitin and proteasome pathways 1
- Protein Degradation and Inhibitors 1
- Hedgehog Signaling Pathway Studies 1
-
- Prostate Cancer Treatment and Research 2
- Co-authors
- Ralph Buttyan (2 shared papers)Na Li (2 shared papers)Mannan Nouri (2 shared papers)Amy A. Lubik (1 shared paper)Colleen C. Nelson (1 shared paper)Mike Wang (1 shared paper)Martin Gleave (1 shared paper)Brett G. Hollier (1 shared paper)
- Journals
- Biophysical Journal (1 paper)Breast Cancer Research (1 paper)Clinical Cancer Research (1 paper)International Journal of Molecular Sciences (1 paper)Molecular and Cellular Endocrinology (1 paper)
- Partner nations
- CanadaUnited KingdomAustralia
In The Last Decade
Jane Foo
4 papers receiving 54 citations
Peers
Comparison fields: 5 of 20
- Cancer Research 15
- Pulmonary and Respiratory Medicine 18
- Oncology 12
- Molecular Biology 32
- Computational Theory and Mathematics 4
Countries citing papers authored by Jane Foo
This map shows the geographic impact of Jane Foo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Foo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Foo more than expected).
Fields of papers citing papers by Jane Foo
This network shows the impact of papers produced by Jane Foo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Foo. The network helps show where Jane Foo may publish in the future.
Co-authors
The 25 scholars most cited alongside Jane Foo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 30 | |
| 2 | 2022 | 11 | |
| 3 | 2020 | 10 | |
| 4 | 2024 | 3 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 0 |
About Jane Foo
Jane Foo is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Computational Theory and Mathematics and Endocrinology, Diabetes and Metabolism, having authored 6 papers that have together received 54 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (2 papers), Estrogen and related hormone effects (1 paper), Ubiquitin and proteasome pathways (1 paper), Computational Drug Discovery Methods (1 paper), Cytokine Signaling Pathways and Interactions (1 paper), Protein Degradation and Inhibitors (1 paper), Hormonal and reproductive studies (1 paper) and Hedgehog Signaling Pathway Studies (1 paper). The work is most often cited by research in Cancer Research (15 citations), Pulmonary and Respiratory Medicine (18 citations), Oncology (12 citations), Molecular Biology (32 citations) and Computational Theory and Mathematics (4 citations). Jane Foo has collaborated with scholars based in Canada, United Kingdom and Australia. Frequent co-authors include Ralph Buttyan, Na Li, Mannan Nouri, Amy A. Lubik, Colleen C. Nelson, Mike Wang, Martin Gleave, Brett G. Hollier, Ladan Fazli and Ahn R. Lee. Their work appears in journals such as Biophysical Journal, Breast Cancer Research, Clinical Cancer Research, International Journal of Molecular Sciences and Molecular and Cellular Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.